Blog
03-12-2025Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat used without other antivirals did not reduce...
mpox
Tecovirimat Is Safe but Ineffective as Treatment for Clade II Mpox - Blog
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain 12-16-2024Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat did not reduce the time to lesion resolution... - Blog
First Case of Clade I Mpox Diagnosed in the United States 11-22-2024Cross-postedfromCDC Health Alert Network Distributed via the CDC Health Alert Network November 18,... - Blog
KFF/Greater Than HIV: FREE Mpox Digital Graphics and Videos 07-12-2024Get the word out about mpox vaccination! It s important to promote mpox vaccination in communities across the... - Blog
CDC MMWR Articles: Mpox Vaccine Effectiveness & Ongoing Importance of Two-Dose Vaccine 05-24-2024In its Morbidity and Mortality Weekly Report, CDC has released the results of studies highlighting the protectio... - Blog
Help Scientists Find a Safe and Effective Mpox Treatment 05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can.… - Blog
Get Ready for Pride Season: Get Protected Against Mpox 03-26-2024During the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov spoke with Dr. John Brooks, chief medical officer of CDC's Division of H… - Blog
JAMA Viewpoint: Lessons From the Mpox Response 01-16-2024CDC and White House leaders published a JAMA Viewpoint on January 8, 2024, discussing key lessons from the natio... - Blog
HRSA HIV/AIDS Bureau Releases Letter on Sexually Transmitted Infections, Including Mpox 06-07-2023As sexually transmitted infections (STIs), including the recent mpox outbreak, continue to have a disproportiona... - Blog
NIAID Study Describes Immune Response to Mpox in Woman Living with HIV 05-25-2023Cross-posted from NIAID Now Mpoxhas been present in west, central and east Africa for decades, with the f... - Blog
CDC MMWR Articles Highlight JYNNEOS Vaccine Effectiveness in Preventing Mpox 05-18-2023On May 18, 2023, CDC issued in its Morbidity and Mortality Weekly Report (PDF, 0.99MB) (MMWR) the results of two... - Blog
Register Now: Virtual Mpox Research Gathering 03-21-2023Register for an open, virtual gathering to discuss mpox research. When: Friday, March 31, 2023, at 9:30am ET (U... - Blog
ICYMI: Research Roundup from CROI 2023 03-10-2023Last month, HIV.gov had the opportunity to speak with our colleagues from NIH, CDC, and HRSA and with community... - Blog
New Mpox Videos Available on HIV.gov 12-14-2022New today: Please watch and share 14 videos featuring White House National Mpox Response Deputy Coordinator Dr.... - Blog
Community-led Monkeypox Vaccine Locator Invites Input 11-21-2022Building Healthy Online Communities(BHOC) invites the community to add vaccine events and help promote its... - Blog
Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022 10-26-2022Cross-posted from: Centers for Disease Control and Prevention Today, CDC issued in its Morbidity and Mortality... - Blog
CDC Science Brief on Monkeypox Virus Detection and Transmission 10-18-2022Today, CDC published a science brief on the detection and transmission of monkeypox, summarizing the latest avai... - Blog
National Monkeypox Response - Closing Day at USCHA 10-12-2022On the closing day of the 2022 US Conference on HIV/AIDS (USCHA) in Puerto Rico, the final plenary session focused on the response to the current monkeypox outb… - Blog
Monkeypox Vaccine Performance Data & Vaccine Expansion Eligibility 09-29-2022Dear Partners, [September 28, 2022], CDC is announcing expanded eligibility for monkeypox vaccination so that... - Blog
Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 09-12-2022Cross-posted from Centers for Disease Control and Prevention On Friday, September 9, 2022, CDC issued in its Mo...